Overall survival (OS) data, published simultaneously by the Journal of Clinical Oncology, 2 show the longest survival data ...
No racial or ethnic group in Arlington comes close to earning enough household income to afford median priced single-family ...
Take your real estate business to the next level with TRD Data access. A one-stop resource that provides exclusive access to ...
See how family income compares across generations, what it means for your financial health, and how improving earnings can ...
In the intent-to-treat population, the median progression-free survival (PFS) was 8.77 months with giredestrant plus Afinitor ...
The proposal will next head to the Powhatan County Board of Supervisors for a deciding vote at its Oct. 27 meeting.
After upstaging Merck & Co.’s Keytruda as a monotherapy for patients with first-line non-small cell lung cancer (NSCLC) in ...
On October 19, 2025, Akeso (9926.HK) announced the final analysis results from the COMPASSION-15/AK104-302 study ...
The addition of tiragolumab to Tecentriq and Avastin did not significantly improve progression-free survival in ...
Medpage Today on MSN
First Survival Win for CDK4/6 Inhibitors in High-Risk Early-Breast Cancer
BERLIN -- For the first time in a phase III trial, adjuvant treatment with a CDK4/6 inhibitor significantly improved overall ...
Title: Biparatopic anti-HER2 antibody drug conjugate (ADC) JSKN003 in the treatment of primary platinum-refractory ovarian cancer (OC) Presentation Number: 1079P Onsite Poster display date: Saturday, ...
The plan has drawn pushback from the building and real estate industries, along with residents who want to renovate.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback